[SRNE] QoQ Quarter Result on 30-Sep-2014 [#Q3]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
04-Nov-2014
Financial Year
2014
Quarter
30-Sep-2014 [#Q3]
Profit Trend
QoQ- 10.04%
YoY- -126.61%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Revenue 1,173 977 798 1,276 775 976 101 415.15%
PBT -10,975 -10,616 -10,207 -7,605 -8,454 -10,093 -11,296 -1.90%
Tax -17 -178 1 2 5 4 4 -
NP -10,958 -10,438 -8,505 -7,605 -8,454 -10,093 -11,296 -2.01%
Tax Rate - - - - - - - -
Total Cost 12,131 11,415 9,303 8,881 9,229 11,069 11,397 4.26%
Ratio Analysis
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
NP Margin -934.19 -1,068.37 -1,065.79 -596.00 -1,090.84 -1,034.12 -11,217.68 -81.01%
Per Share
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
EPS -0.30 -0.29 -0.23 -0.27 -0.33 -0.44 -0.49 -27.96%
EPS Diluted -0.30 -0.29 -0.23 -0.27 -0.33 -0.44 -0.49 -27.96%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.